Trials / Unknown
UnknownNCT00043433
Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 35 (planned)
- Sponsor
- Tularik · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether T900607-sodium is effective and safe in treating hepatocellular carcinoma, a type of liver cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intravenous T900607-sodium |
Timeline
- Start date
- 2002-07-01
- First posted
- 2002-08-12
- Last updated
- 2005-06-24
Locations
12 sites across 2 countries: United States, China
Source: ClinicalTrials.gov record NCT00043433. Inclusion in this directory is not an endorsement.